Literature DB >> 7554382

HLA-DR-restricted T cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase.

G C Huang1, J Tremble, E Bailyes, S D Arden, T Kaye, A M McGregor, J P Banga.   

Abstract

T cells reacting with pancreatic islet beta cell proteins play a pivotal role in the pathogenesis of type 1 diabetes in experimental animal models and man, although the islet cell autoantigens against which these T cells are directed remain to be characterized. We have previously shown the presence of disease-related antigens residing in the transplantable RIN insulinoma membranes which are recognized by T cells from diabetic NOD mice. We now report on the establishment of CD4+, T cell lines reacting with insulinoma membranes from six newly diagnosed type 1 diabetic patients. Detailed examination of T cell lines from two patients revealed that both the lines continued to react with normal islet cell proteins and, interestingly, were also stimulated by antigens present in brain microsomes. The two T cell lines showed reactivity with different molecular weight proteins of the insulinoma membranes and both the lines were histocompatibility-linked antigen (HLA)-DR restricted. Although the insulinoma membrane preparation is known to contain glutamic acid decarboxylase (GAD), none of the six T cell lines proliferates in response to purified GAD. These T cell lines will be valuable in characterizing novel islet beta cell antigens which are likely to be implicated in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554382      PMCID: PMC1553330          DOI: 10.1111/j.1365-2249.1995.tb06649.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Antigen-specific T cell recognition of affinity-purified and recombinant thyroid peroxidase in autoimmune thyroid disease.

Authors:  D L Ewins; P S Barnett; S Ratanachaiyavong; C Sharrock; J Lanchbury; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 2.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes.

Authors:  B O Roep; A A Kallan; W L Hazenbos; G J Bruining; E M Bailyes; S D Arden; J C Hutton; R R de Vries
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

4.  Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus.

Authors:  R J Keller
Journal:  J Autoimmun       Date:  1990-06       Impact factor: 7.094

5.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.

Authors:  S Baekkeskov; H J Aanstoot; S Christgau; A Reetz; M Solimena; M Cascalho; F Folli; H Richter-Olesen; P De Camilli; P D Camilli
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

6.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

Authors:  R Martin; D Jaraquemada; M Flerlage; J Richert; J Whitaker; E O Long; D E McFarlin; H F McFarland
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

7.  Mapping epitope specificities of monoclonal antibodies to thyroid peroxidase using recombinant antigen preparations.

Authors:  D L Ewins; P S Barnett; R W Tomlinson; A M McGregor; J P Banga
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

8.  Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes.

Authors:  M A Atkinson; D L Kaufman; L Campbell; K A Gibbs; S C Shah; D F Bu; M G Erlander; A J Tobin; N K Maclaren
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

Review 9.  HLA and insulin-dependent diabetes. A protective perspective.

Authors:  M J Sheehy
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

10.  Regulation of insulin mRNA abundance and adenylation: dependence on hormones and matrix substrata.

Authors:  R Muschel; G Khoury; L M Reid
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

View more
  1 in total

1.  Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients.

Authors:  T I Tree; D O'Byrne; J M Tremble; W M MacFarlane; K Haskins; R F James; K Docherty; J C Hutton; J P Banga
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.